My Watchlist

Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

Recs

1

This Oil Maker Gets Krilled

By | More Articles
November 27, 2012 | Comments (0)

Neptune Technologies (Nasdaq: NEPT  ) suffered a major setback in a tragic explosion to its main production facility in Quebec on Nov. 8. Since then and up until today, trading in the company's shares had been frozen. Markets reacted by sending shares down 24%, reflecting the major production setback from the destroyed facility. The loss will impact the company's main product, a krill-oil-based nutritional supplement. However, one of its subsidiaries has aspirations to compete with fish-oil based pharmaceuticals from companies such as Amarin (Nasdaq: AMRN  ) and GlaxoSmithKline (NYSE: GSK  ) .

For Amarin, the success of its new triglyceride lowering drug is key to the company's future success or failure, and is a hugely followed story on Fool.com. The company has huge potential, but don't invest a dollar before reading everything you need to know about Amarin. You can start now with top Fool.com analyst Max Macaluso's premium research report. Click here now to keep reading.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Brenton Flynn has no positions in the stocks mentioned above. Max Macaluso has no positions in the stocks mentioned above. The Motley Fool owns shares of GlaxoSmithKline. Motley Fool newsletter services recommend GlaxoSmithKline. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 2129222, ~/Articles/ArticleHandler.aspx, 5/25/2013 8:48:18 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 11 hours ago Sponsored by:
DOW 15,303.10 8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
NASD 3,459.14 -0.28 -0.01%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/24/2013 3:59 PM
NEPT $2.76 Down -0.09 -3.16%
Neptune Technologi… CAPS Rating: *
GSK $52.97 Up +0.24 +0.46%
GlaxoSmithKline CAPS Rating: ****
AMRN $6.78 Down -0.14 -2.02%
Amarin Corp plc (A… CAPS Rating: ***

Advertisement